Skip to main content
TipRanks
Go Ultimate75% OFF

Ehealth (EHTH) AI Stock Analysis

1,042 Followers
EHTH

Ehealth

(NASDAQ:EHTH)

Select Model
Rating:51Neutral
Price Target:$0.35▲(0.57% Upside)
Action:reiterated
Date:11/18/26

The score is held back primarily by weak technicals (price far below key moving averages with bearish momentum) and financial-quality concerns driven by historically inconsistent cash generation and a notable recent equity decline. These risks are partly offset by improved profitability versus prior years and management’s reaffirmed guidance focused on cost reductions and operating cash flow improvement, but valuation remains difficult to support with a negative P/E and no dividend yield provided.

Positive Factors
Cost disciplineThe planned cost reduction is substantial relative to the company’s recent operating challenges and can improve breakeven economics if maintained. Lower fixed, marketing, and service costs should provide greater flexibility to pursue profitable enrollment while supporting management’s cash-flow objectives.
Negative Factors
Medicare contractionThe magnitude of the Medicare decline indicates a material weakening in the company’s core enrollment engine, not merely modest quarterly volatility. Lower applications and revenue can reduce commission generation, impair operating leverage, and make a durable return to growth more difficult.

Ehealth (EHTH) vs. SPDR S&P 500 ETF (SPY)

-100%-75%-50%-25%0%25%50%75%EHTH-89.47%SPY+11.73%Dec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
Market Cap
$11.32M
Dividend Yield
―
Average Volume (3M)
428.08K
Price to Earnings (P/E)
-0.4
Beta (1Y)
1.20
Revenue Growth
-13.60%
EPS Growth
-899.66%
Country
US
Employees
1,665
Sector
Financial
Sector Strength
68
Industry
Insurance - Brokers

Ehealth Business Overview & Revenue Model

Company Description

eHealth, Inc. operates a digital health insurance marketplace within the United States, dedicated to engaging consumers, educating them, and simplifying the health insurance enrollment process. Its operations are categorized into two main divisions:...

How the Company Makes Money

eHealth primarily makes money by acting as a distribution and enrollment channel for health insurers and related plan providers. Its core revenue is generated when a consumer enrolls in an insurance plan through eHealth’s websites, call centers, or a...

Ehealth Earnings Call Summary

Earnings Call Date:Nov 04, 2026(Q3-2026)|% Change Since:-44.95%|Next Earnings Date:Mar 02, 2027
Earnings Call SentimentNeutral

The call presented a mixed picture. Management highlighted substantial cost reductions, sharply improved year-to-date cash flow, favorable early AEP demand, early retention and ancillary cross-sell gains from the Lifetime Advisory Model, new carrier and distribution partnerships, and reaffirmed guidance. However, current-quarter financial performance remained weak, with significant declines in revenue, applications, Medicare tail revenue, Medicare gross profit, segment economics and cash balances, alongside ongoing preferred equity capital structure discussions. The positive operational and strategic developments were offset by the magnitude of the current financial declines, resulting in a balanced outlook.

Positive Updates

Improved Year-to-Date Operating Cash Flow
Operating cash flow increased to $19.6 million for the first 9 months of 2026 from $10.6 million in the same period a year ago, which management described as nearly doubling and an 85% year-over-year improvement. The company expects fourth quarter operating cash flow to show a meaningful improvement compared with Q4 2025 and remains on track for breakeven or better operating cash flow for the full year.

Negative Updates

Third-Quarter Revenue and Profitability Decline
Third-quarter revenue was $21.3 million, while GAAP net loss was $35.9 million and adjusted EBITDA loss was $39.9 million. Management said the results were in line with expectations, but revenue continued to decline year over year.

Company Guidance

Management reaffirmed its fiscal year 2026 guidance ranges, including full-year operating cash flow at “breakeven or better,” 2026 net adjustment revenue in the range of $17 million to $20 million, total 2026 cost savings of more than $60 million, fixed cost savings of approximately $30 million, and a reduction in 2026 variable and fixed operating costs and expenses by approximately $90 million compared with 2025; fourth quarter operating cash flow is currently expected to also show a meaningful improvement compared to Q4 of '25, while the company’s longer-term objectives include returning to mid-single-digit revenue growth in 2027, accompanied by expanded adjusted EBITDA margins and positive operating cash flow.

Ehealth Financial Statement Overview

Summary

Income statement shows a meaningful turnaround to profitability versus 2021–2023 losses, and leverage appears moderate-to-low. However, cash flow consistency is a major weakness (multi-year negative OCF/FCF through 2025 with volatility), and the sharp equity decline from 2025 to TTM 2026 reduces the capital cushion.

Income Statement

68Positive

Balance Sheet

72Positive

Cash Flow

43Neutral
Financial statement breakdown
BreakdownTTMDec 2025Dec 2024Dec 2023Dec 2022Dec 2021
Income Statement
Total Revenue469.10M554.01M532.41M452.87M405.36M538.20M
Gross Profit462.63M540.25M530.62M451.10M403.71M536.21M
EBITDA64.28M83.25M46.81M295.00K-77.65M-105.18M
Net Income22.95M40.04M10.06M-28.21M-88.72M-104.38M
Balance Sheet
Total Assets1.11B1.26B1.16B1.11B1.11B1.15B
Cash, Cash Equivalents and Short-Term Investments88.12M77.22M82.24M121.65M144.40M123.23M
Total Debt131.59M134.35M96.92M103.16M106.80M41.37M
Total Liabilities200.92M288.82M567.00M209.26M461.66M399.77M
Stockholders Equity912.72M973.65M588.43M904.08M650.96M749.52M
Cash Flow
Free Cash Flow12.34M-40.65M-31.22M-17.47M-42.38M-183.48M
Operating Cash Flow19.38M-25.34M-18.37M-6.69M-26.87M-162.62M
Investing Cash Flow-61.61M25.43M-48.42M-15.89M25.86M-12.63M
Financing Cash Flow36.71M34.29M-9.32M-6.22M63.84M213.24M

Ehealth Technical Analysis

Technical Analysis SentimentNegative
Last Price0.35

Price Trends

50DMA0.65Negative
100DMA0.99Negative
200DMA1.33Negative

Market Momentum

MACD-0.08Positive
RSI26.59Positive
STOCH5.48Positive

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For EHTH, the sentiment is Negative. The current price of 0.35 is below the 20-day moving average (MA) of 0.50, below the 50-day MA of 0.65, and below the 200-day MA of 1.33, indicating a bearish trend. The MACD of -0.08 indicates Positive momentum. The RSI at 26.59 is Positive, neither overbought nor oversold. The STOCH value of 5.48 is Positive, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for EHTH.

Ehealth Risk Analysis

Ehealth disclosed 41 risk factors in its most recent earnings report. Ehealth reported the most risks in the "Finance & Corporate" category.

Higher RiskSector Avg.Lower RiskFinance & CorporateTech & InnovationLegal & RegulatoryProductionAbility to SellMacro & Political
Finance & Corporate - Financial and accounting risks. Risks related to the execution of corporate activity and strategy

Latest Risks Added

3 New Risks
1.We are a "smaller reporting company," and the scaled disclosure requirements applicable to smaller reporting companies may make our common stock less attractive to investors.Q4, 2025
2.Our business depends on our ability to maintain and improve functioning information technology systems that support our ecommerce platform and advisor enrollment center operations, particularly during key health care enrollment periods.Q4, 2025
3.Our business could be harmed if we are not successful in executing on our operational and strategic plans.Q4, 2024

Ehealth Peers Comparison

Overall Rating

UnderperformOutperform
Sector (68)

Financial Indicators

EHTH against its peers
NameOverall RatingMarket CapP/E RatioROEDividend YieldRevenue GrowthEPS Growth
WDHWDH83Outperform$364.49M0.6010.56%5.94%76.04%25.89%
HUIZHUIZ68Neutral$22.94M0.286.41%―――
Sector *68Neutral$18.00B11.429.92%3.81%9.73%1.22%
SLQTSLQT63Neutral$58.41M-33.4011.28%―0.42%-111.55%
EHTHEHTH51Neutral$11.32M-0.362.70%―-13.60%-899.66%
XGPUXGPU41Neutral$3.32M-0.11-88.14%―-20.76%89.78%
AIFUAIFU34Underperform$706.17M-0.14-150.44%―-47.11%-87.98%

* Financial Sector Average

Performance Comparison

-50%0%EHTHAIFUXGPUHUIZSLQTWDHDec '25Jan '26Feb '26Mar '26Apr '26May '26Jun '26Jul '26Aug '26Sep '26Oct '26Nov '26
EHTH and its peers over the selected period
Show on chartTickerCompany NamePriceChange% Change
EHTHEhealth0.35-3.25-90.31%
AIFUFanhua Inc.9.76-66.04-87.13%
XGPUReliance Global Group1.88-26.94-93.48%
HUIZHuize Holding Ltd.2.27-0.83-26.77%
SLQTSelectQuote Inc6.51-21.29-76.58%
WDHWaterdrop, Inc. ADR Class A1.01-0.56-35.63%

Ehealth Corporate Events

Delistings and Listing ChangesRegulatory Filings and ComplianceStock Split

eHealth Faces Nasdaq Noncompliance, Weighs Reverse Stock Split

Negative
Oct 16, 2026

On October 14, 2026, eHealth, Inc. disclosed that it received a notice from Nasdaq stating its common stock had closed below the $1.00 minimum bid price for 30 consecutive business days, putting the company out of compliance with the Nasdaq Global Se...

Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.

Disclaimer

This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.

Date of analysis: Nov 18, 2026